Condensed Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues:
OptiChem revenue	$ 12,797	$ 5,115	$ 35,848	$ 37,033
Total revenues	12,797	5,115	35,848	37,033
Costs and expenses:
Research and development	2,654,005	200,094	6,996,462	402,849
Sales, general and administrative	1,052,042	1,632,984	2,915,549	2,795,187
Amortization	19,211	10,615	57,692	139,373
Depreciation	84,208	551	191,161	1,581
Total costs and expenses	3,809,466	1,844,244	10,160,864	3,338,990
Loss from operations	(3,796,669)	(1,839,129)	(10,125,016)	(3,301,957)
Other expense	(8,951)	(2,001,615)	(10,432)	(1,968,230)
Interest and dividend income	9,006	4,400	12,991	10,509
Total other income / (expense)	55	(1,997,215)	2,559	(1,957,721)
Net loss	(3,796,614)	(3,836,344)	(10,122,457)	(5,259,678)
Net loss per share:
Basic and diluted net loss per share	$ (0.10)	$ (0.15)	$ (0.28)	$ (0.33)
Weighted average shares outstanding	39,774,961	25,004,820	35,991,378	16,057,977
Other comprehensive loss:
Net loss	(3,796,614)	(3,836,344)	(10,122,457)	(5,259,678)
Net unrealized gain/(loss) on available-for-sale investments	10,907		10,907
Comprehensive loss	$ (3,785,707)	$ (3,836,344)	$ (10,111,550)	$ (5,259,678)